he 11 has been researched along with Arrhythmia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chazov, EI; Glushkov, RG; Golitsyn, SP; Iuzhakov, SD; L'vov, AI; Rozenshtraukh, LV; Ruda, MIa | 1 |
| Chazov, EI; Dorodnikova, EV; Glushkov, RG; Golitsyn, SP; Iuzhakov, SD; Maĭkov, EB; Mashkovskiĭ, MD; Merkulova, IN; Rozenshtraukh, LV; Ruda, MIa; Skachilova, SIa | 1 |
2 other study(ies) available for he 11 and Arrhythmia
| Article | Year |
|---|---|
[Development of original Russian antiarrhythmic drugs of the 3rd class].
Topics: Adolescent; Adult; Aged; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzamides; Clinical Trials as Topic; Dogs; Electrocardiography; Female; Humans; Male; Middle Aged; Phenethylamines; Potassium Channel Blockers; Purkinje Fibers; Rabbits; Russia; Sulfonamides; Time Factors | 2003 |
[The first original Russian class-III antiarrhythmic nibentan].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzamides; Dogs; Dose-Response Relationship, Drug; Drug Evaluation; Drug Evaluation, Preclinical; Electrocardiography; Electrophysiology; Humans; Rats | 1998 |